By Dean Seal

DiaCarta Ltd. said U.S. regulators have granted Emergency Use Authorization to its test kit for monkeypox infections.

The molecular diagnostics and disease-testing company said Thursday morning that the U.S. Food and Drug Administration extended the approval to its QuantiVirus MPXV test.

The test detects the monkeypox virus from lesion swabs and is designed for laboratory use.

DiaCarta agreed in October to be acquired and taken public by the blank-check company HH&L Acquisition Co. in a deal that gave DiaCarta an implied pre-money equity value of $460 million. The merger is expected to close this quarter.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

January 12, 2023 09:07 ET (14:07 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
HH&L Acquisition (NYSE:HHLA)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more HH&L Acquisition Charts.
HH&L Acquisition (NYSE:HHLA)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more HH&L Acquisition Charts.